Business Description
Sprint Bioscience AB
ISIN : SE0006343745
Compare
Compare
Traded in other countries / regions
SPRINT.Sweden5JA1.Germany IPO Date
2014-11-07Description
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.45 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -2.8 | |||||
| Beneish M-Score | 562.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.2 | |||||
| 3-Year EBITDA Growth Rate | 75.6 | |||||
| 3-Year EPS without NRI Growth Rate | 83.7 | |||||
| 3-Year Book Growth Rate | 4.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68 | |||||
| 9-Day RSI | 62.61 | |||||
| 14-Day RSI | 60.66 | |||||
| 6-1 Month Momentum % | -39.89 | |||||
| 12-1 Month Momentum % | 65.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.67 | |||||
| Quick Ratio | 1.67 | |||||
| Cash Ratio | 1.44 | |||||
| Days Sales Outstanding | 2.92 | |||||
| Days Payable | 162.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.7 | |||||
| Shareholder Yield % | -0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 82.77 | |||||
| Operating Margin % | -5.01 | |||||
| Net Margin % | -0.87 | |||||
| FCF Margin % | 45.3 | |||||
| ROE % | -2.03 | |||||
| ROA % | -1 | |||||
| ROIC % | -11.9 | |||||
| ROC (Joel Greenblatt) % | -96.69 | |||||
| ROCE % | -11.62 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 4.46 | |||||
| PS Ratio | 1.84 | |||||
| PB Ratio | 3.35 | |||||
| Price-to-Tangible-Book | 3.5 | |||||
| Price-to-Free-Cash-Flow | 4.06 | |||||
| Price-to-Operating-Cash-Flow | 4.06 | |||||
| EV-to-EBIT | -18.89 | |||||
| EV-to-EBITDA | -22.96 | |||||
| EV-to-Revenue | 0.95 | |||||
| EV-to-FCF | 1.97 | |||||
| Price-to-Net-Current-Asset-Value | 4.24 | |||||
| Price-to-Net-Cash | 6.36 | |||||
| Earnings Yield (Greenblatt) % | -5.28 | |||||
| FCF Yield % | 23.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sprint Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 50.485 | ||
| EPS (TTM) (kr) | -0.02 | ||
| Beta | 0 | ||
| Volatility % | 212.59 | ||
| 14-Day RSI | 60.66 | ||
| 14-Day ATR (kr) | 0.150209 | ||
| 20-Day SMA (kr) | 1.3363 | ||
| 12-1 Month Momentum % | 65.76 | ||
| 52-Week Range (kr) | 0.451 - 3.28 | ||
| Shares Outstanding (Mil) | 69.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sprint Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sprint Bioscience AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sprint Bioscience AB Frequently Asked Questions
What is Sprint Bioscience AB(OSTO:SPRINT)'s stock price today?
The current price of OSTO:SPRINT is kr1.40. The 52 week high of OSTO:SPRINT is kr3.28 and 52 week low is kr0.45.
When is next earnings date of Sprint Bioscience AB(OSTO:SPRINT)?
The next earnings date of Sprint Bioscience AB(OSTO:SPRINT) is 2024-08-23 Est..
Does Sprint Bioscience AB(OSTO:SPRINT) pay dividends? If so, how much?
Sprint Bioscience AB(OSTO:SPRINT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers